Dying for drugs: Drug companies should swear “Hippocratic” oathBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7410.343-b (Published 07 August 2003) Cite this as: BMJ 2003;327:343
- Swethajit Biswas, specialist registrar in medical oncology (email@example.com)
- Oncology Centre, Addenbrooke's Hospital, Cambridge CB2 2QQ
EDITOR—Aronson's review of the television programme Dying for Drugs shows that the relation between medicine and drug companies is multifaceted.1 As a clinician you cannot practise without them, but at times you want to get rid of them for being unfaithful to your patients.
With the current academic …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial